![Title](/content/hub5/2024-spring-drug-insights-report/_jcr_content/root/container/container/o5_two_column/col1/o5_adaptiveimage.jpg)
Novel treatments, increased choice and competition
This edition of the Drug Pipeline Insights Report showcases:
- Second gene therapy for hemophilia B
- Nontraditional RSV vaccine
- Maintenance treatment for COPD
Related content
![](/content/dam/o4-dam/images/professionals/pharmacies/orx-dpir-winter-2024-image-1080x720.jpg)
Winter: First big drugs for 2024
New treatments for NASH, schizophrenia and more are on the way.
![](/content/dam/optum4/images/sub-folder/1473793-hemophilia-image-card-minute3-500x350.png)
A young patient’s hemophilia story
See how OptumRx helped change a patient’s life.
![](/content/dam/o4-dam/images/professionals/pharmacies/pill-and-injection-1080x720.jpg)
Optum Rx Drug Pipeline Insights Reports
Read the most recent quarterly reports on new drugs coming down the pipeline.